Image

Middle East and Africa Medical Cannabis Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Apr 2021
  • MEA
  • 350 Pages
  • No of Tables: 198
  • No of Figures: 51

Middle East and Africa Medical Cannabis Market, By Product (Oil, Dried Medical Cannabis, Medical Cannabis Capsules, Vape Pen, Whole Flower, Creams & Moisturizer, Ground Flower, Patch, Mask & Serum, Cleanser, Others), Source (Natural, Synthetic), Species (Sativa, Hybrid, Cannabis Indica), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol, Cannabigerol (CBG), Cannabinol, Others), Application (Pain Management, Anxiety, Muscle Spasms, Nausea, Appetite Loss, Cancer, Arthritis, Alzheimer's Disease, Epilepsy, Depression and Sleep Disorders, Multiple Sclerosis, Autism, Mental Health Conditions, Elevate Mood, Others), Route of Administration (Oral Solutions and Capsules, Smoking, Topicals, Vaporizers, Others), End User (Homecare Settings, Hospital and Rehab Centers, Pharmaceutical Industry, Research and Development Centers, Others), Distribution Channel (B2C, B2B), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Middle East and Africa Medical Cannabis Market

Market Analysis and Insights: Middle East and Africa Medical Cannabis Market

The medical cannabis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 21.53% in the forecast period of 2021 to 2028 and is expected to reach USD 787.73 million by 2028.

Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. For several years, it has been used medicinally and has wide range of application in treatment of various diseases including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS and Alzheimer’s among others.

The use of cannabis as medicine is not rigorously tested due to the government restrictions and resulting in limited clinical research to define the efficacy of cannabis in medical and clinical applications. However, preliminary studies suggests that cannabis can reduce vomiting and nausea in chemotherapy patients and helps in increasing the appetite.

The increased medicinal use of cannabis and controlled legalization and use of cannabis in various industries are driving the growth of the market.

The medical cannabis market provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Medical Cannabis Market

Middle East and Africa Medical Cannabis Market Scope and Market Size

The medical cannabis market is categorized into eight notable segments which are based on the product, source, species, derivatives, application, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the medical cannabis market is segmented into oil, medical cannabis capsules, patch, whole flower, ground flower, vape pen, dried medical cannabis, creams & moisturizer, mask & serum, cleanser and others. In 2021, oil segment is expected to dominate the medical cannabis market due to high technology adoption by key players in the market.
  • On the basis of source, the medical cannabis market is segmented into synthetic and natural. In 2021, synthetic segment is expected to dominate the medical cannabis market because of increasing healthcare expenditure.
  • On the basis of species, the medical cannabis market is segmented into cannabis indica, sativa and hybrid. In 2021, cannabis indica segment is expected to dominate the medical cannabis market because of increased medicinal use of cannabis.
  • On the basis of derivatives, the medical cannabis market is segmented into cannabidiol (CBD), tetrahydrocannabinol (THC)/delta-8-tetrahydrocannabinol, cannabinol, cannabigerol (CBG) and others. In 2021, cannabidiol (CBD) segment is expected to dominate the medical cannabis market due to increasing demand of medical marijuana products in the market.
  • On the basis of application, the medical cannabis market is segmented into Alzheimer’s disease, appetite loss, cancer, epilepsy, autism, mental health conditions, multiple sclerosis, pain management, nausea, muscle spasms, arthritis, elevate mood, depression and sleep disorders, anxiety and others. In 2021, Alzheimer’s disease segment is expected to dominate the medical cannabis market because of increasing R&D activities.
  • On the basis of route of administration, the medical cannabis market is segmented into oral solutions and capsules, smoking, vaporizers, topicals and others. In 2021, oral solutions and capsules segment is expected to dominate the medical cannabis market because of rising prevalence of chronic diseases.
  • On the basis of end user, the medical cannabis market is segmented into pharmaceutical industry, research and development centers, homecare settings, hospital and rehab centers and others. In 2021, pharmaceutical industry segment is expected to dominate the medical cannabis market because of increasing geriatric population and prevalence of chronic diseases.
  • On the basis of distribution channel, the medical cannabis market is segmented into B2B and B2C. In 2021, B2B segment is expected to dominate the medical cannabis market because of increasing demand of cannabis for medical and clinical purposes.

Medical Cannabis Market Country Level Analysis

The medical cannabis market is analysed and market size information is provided by the country, product, source, species, derivatives, application, route of administration, end user and distribution channel as referenced above.

The countries covered in the Middle East and Africa medical cannabis market report are South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.

South Africa is dominating the market due to advanced methodologies present in the field which are also propelling the growth of the medical cannabis market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

New Product Launches by Manufacturers is creating new opportunities for Players in the Medical Cannabis Market

The medical cannabis market also provides you with detailed market analysis for every country growth in aesthetic industry with medical cannabis market sales, impact of advancement in the medical cannabis market and changes in regulatory scenarios with their support for the medical cannabis market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Medical Cannabis Market Share Analysis

The medical cannabis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to medical cannabis market.

Some of the major players operating in the medical cannabis market are Tilray, Elixinol Middle East & Africa Limited, Medical Marijuana, Inc., Peace Naturals Project Inc., BOL Pharma, PharmaHemp, Kiehl’s (A Subsidiary of L'ORÉAL), CANOPY GROWTH CORPORATION, Aurora Cannabis, HUMBOLDT SEED COMPANY, Crop King Seeds, BARNEY'S FARM, and Aphria Inc. among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product developments are also initiated by the companies worldwide which are also accelerating the growth of medical cannabis market.

For instance,

  • In December 2020, Aphria Inc. announced that it has entered in an agreement with Tilray to combine their business and will create the world’s largest Middle East and Africa cannabis company. This will help the company to further diversify its market in coming years.

Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the medical cannabis market which also provides the benefit for organisation to improve their offering for medical cannabis market.

Customization Available: Middle East and Africa Medical Cannabis Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 ANNUAL COST OF CULTIVATION:

TABLE 2 ANNUAL COST OF MANUFACTURING:

TABLE 3 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED

TABLE 4 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY ANXIETY, BY REGION, 2021-2028 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA NAUSEA IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA CANCER IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA AUTISM IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 52 MIDDLE EAST AND AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 53 MIDDLE EAST AND AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 55 MIDDLE EAST AND AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 65 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 66 MIDDLE EAST AND AFRICA NATURAL IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 67 MIDDLE EAST AND AFRICA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 68 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2019-2028 (USD MILLION)

TABLE 69 MIDDLE EAST AND AFRICA SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 70 MIDDLE EAST AND AFRICA HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 71 MIDDLE EAST AND AFRICA CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 72 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 73 MIDDLE EAST AND AFRICA ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 74 MIDDLE EAST AND AFRICA SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 75 MIDDLE EAST AND AFRICA TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 76 MIDDLE EAST AND AFRICA VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 77 MIDDLE EAST AND AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 78 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 79 MIDDLE EAST AND AFRICA HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 80 MIDDLE EAST AND AFRICA HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 81 MIDDLE EAST AND AFRICA REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 82 MIDDLE EAST AND AFRICA PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 83 MIDDLE EAST AND AFRICA RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 84 MIDDLE EAST AND AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 85 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 86 MIDDLE EAST AND AFRICA B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 87 MIDDLE EAST AND AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 88 MIDDLE EAST AND AFRICA B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 89 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

TABLE 90 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 91 MIDDLE EAST AND AFRICA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 92 MIDDLE EAST AND AFRICA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 93 MIDDLE EAST AND AFRICA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 94 MIDDLE EAST AND AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 95 MIDDLE EAST AND AFRICA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 96 MIDDLE EAST AND AFRICA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 97 MIDDLE EAST AND AFRICA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 98 MIDDLE EAST AND AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 99 MIDDLE EAST AND AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 100 MIDDLE EAST AND AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 101 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 102 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 103 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 104 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 105 MIDDLE EAST AND AFRICA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 106 MIDDLE EAST AND AFRICA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 107 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 108 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 109 MIDDLE EAST AND AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 110 MIDDLE EAST AND AFRICA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 111 MIDDLE EAST AND AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 112 MIDDLE EAST AND AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 113 MIDDLE EAST AND AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 114 MIDDLE EAST AND AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 115 MIDDLE EAST AND AFRICA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 116 MIDDLE EAST AND AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 117 MIDDLE EAST AND AFRICA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 118 MIDDLE EAST AND AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 119 MIDDLE EAST AND AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 120 MIDDLE EAST AND AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 121 MIDDLE EAST AND AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 122 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 123 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 124 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 125 MIDDLE EAST AND AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 126 ISRAEL MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 127 ISRAEL TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 128 ISRAEL SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 129 ISRAEL SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 130 ISRAEL DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 131 ISRAEL TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 132 ISRAEL CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 133 ISRAEL SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 134 ISRAEL VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 135 ISRAEL WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 136 ISRAEL GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 137 ISRAEL MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 138 ISRAEL MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 139 ISRAEL MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 140 ISRAEL CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 141 ISRAEL TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 142 ISRAEL CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 143 ISRAEL MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 144 ISRAEL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 145 ISRAEL ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 146 ISRAEL MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 147 ISRAEL NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 148 ISRAEL APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 149 ISRAEL CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 150 ISRAEL ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 151 ISRAEL ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 152 ISRAEL EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 153 ISRAEL DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 154 ISRAEL MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 155 ISRAEL AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 156 ISRAEL MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 157 ISRAEL ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 158 ISRAEL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 159 ISRAEL MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 160 ISRAEL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 161 ISRAEL B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 162 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 163 SOUTH AFRICA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 164 SOUTH AFRICA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 165 SOUTH AFRICA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 166 SOUTH AFRICA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 167 SOUTH AFRICA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 168 SOUTH AFRICA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 169 SOUTH AFRICA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 170 SOUTH AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 171 SOUTH AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 172 SOUTH AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 173 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 174 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 175 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 176 SOUTH AFRICA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 177 SOUTH AFRICA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 178 SOUTH AFRICA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 179 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 180 SOUTH AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 181 SOUTH AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 182 SOUTH AFRICA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 183 SOUTH AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 184 SOUTH AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 185 SOUTH AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 186 SOUTH AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 187 SOUTH AFRICA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 188 SOUTH AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 189 SOUTH AFRICA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 190 SOUTH AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 191 SOUTH AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 192 SOUTH AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 193 SOUTH AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 194 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 195 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 196 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 197 SOUTH AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 198 REST OF MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions